Display options
Cite
Mathy-Hartert M, Deby-Dupont G, Deby C, et al. Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime. Mediators Inflamm. 1995;4(6):437-43doi: 10.1155/S0962935195000706.
Mathy-Hartert, M., Deby-Dupont, G., Deby, C., Jadoul, L., Vandenberghe, A., & Lamy, M. (1995). Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime. Mediators of inflammation, 4(6), 437-43. https://doi.org/10.1155/S0962935195000706
Mathy-Hartert, M, et al. "Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime." Mediators of inflammation vol. 4,6 (1995): 437-43. doi: https://doi.org/10.1155/S0962935195000706
Mathy-Hartert M, Deby-Dupont G, Deby C, Jadoul L, Vandenberghe A, Lamy M. Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime. Mediators Inflamm. 1995;4(6):437-43. doi: 10.1155/S0962935195000706. PMID: 18475677; PMCID: PMC2365676.
Copy Download .nbib Format: NLM
Share it on

Mediators Inflamm. 1995;4(6):437-43. doi: 10.1155/S0962935195000706.

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime.

Mediators of inflammation

M Mathy-Hartert, G Deby-Dupont, C Deby, L Jadoul, A Vandenberghe, M Lamy

Affiliations

  1. Centre for the Biochemistry of Oxygen Institut de Chimie, B6 Université de Liège Domaine Universitaire du Sart Tilman Liège 4000 Belgium.

PMID: 18475677 PMCID: PMC2365676 DOI: 10.1155/S0962935195000706

Abstract

We investigated the effects of the antibiotic ceftazidime (CAZ) on the cytolytic action of the neutrophil myeloperoxidase-hydrogen peroxide-chloride anion system (MPO/H(2)O(2)/Cl(-)). In this system, myeloperoxidase catalyses the conversion of H(2)O(2) and CI(-) to the cytotoxic agent HOCl. Stimulated neutrophils can release MPO into the extracellular environment and then may cause tissue injury through direct endothelial cells lysis. We showed that human umbilical vein endothelial cells (HUVEC) were capable of taking up active MPO. In presence of H(2)O(2) (10(-4) M), this uptake was accompanied by cell lysis. The cytolysis was estimated by the release of (51)Cr from HUVEC and expressed as an index of cytotoxicity (IC). Dose dependent protection was obtained for CAZ concentrations ranging from 10(-5) to 10(-3) M;this can be attributed to inactivation of HOCl by the drug. This protection is comparable to that obtained with methionine and histidine, both of which are known to neutralize HOCl. This protection by CAZ could also be attributed to inactivation of H(2)O(2), but when cytolysis was achieved with H(2)O(2) or O(2) (-) generating enzymatic systems, no protection by CAZ was observed. Moreover, the peroxidation activity of MPO (action on H(2)O(2)) was not affected by CAZ, while CAZ prevented the chlorination activity of MPO (chlorination of monochlorodimedon). So, we concluded that CAZ acts via HOCl inactivation. These antioxidant properties of CAZ may be clinically useful in pathological situations where excessive activation of neutrophils occurs, such as in sepsis.

References

  1. Crit Care Clin. 1993 Apr;9(2):261-98 - PubMed
  2. J Clin Invest. 1993 Jan;91(1):38-45 - PubMed
  3. J Biol Chem. 1989 Aug 15;264(23):13801-9 - PubMed
  4. Mediators Inflamm. 1994;3(2):117-23 - PubMed
  5. Biochem Biophys Res Commun. 1972 May 26;47(4):679-84 - PubMed
  6. J Clin Invest. 1984 Oct;74(4):1489-95 - PubMed
  7. J Biol Chem. 1966 Apr 25;241(8):1769-77 - PubMed
  8. Biochem Biophys Res Commun. 1984 Jul 31;122(2):668-75 - PubMed
  9. Biochim Biophys Acta. 1978 May 11;524(1):45-54 - PubMed
  10. Biochem Pharmacol. 1995 May 11;49(9):1249-54 - PubMed
  11. J Invest Dermatol. 1986 Apr;86(4):449-53 - PubMed
  12. Biochim Biophys Acta. 1988 Oct 7;971(3):266-74 - PubMed
  13. Drugs. 1995 Apr;49(4):577-617 - PubMed
  14. Acta Anaesthesiol Scand Suppl. 1991;95:7-13; discussion 13-4 - PubMed
  15. J Exp Med. 1984 Feb 1;159(2):592-603 - PubMed
  16. Biochem Biophys Res Commun. 1979 May 28;88(2):402-9 - PubMed
  17. N Engl J Med. 1989 Feb 9;320(6):365-76 - PubMed
  18. J Reticuloendothel Soc. 1972 Aug;12(2):170-96 - PubMed
  19. Antimicrob Agents Chemother. 1993 May;37(5):950-6 - PubMed
  20. J Histochem Cytochem. 1989 Apr;37(4):499-508 - PubMed

Publication Types